- Home
- XMTR vs TVTX Comparison
XMTR vs TVTX Comparison
Compare XMTR & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XMTR | TVTX |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.1B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | XMTR | TVTX |
|---|---|---|
| Price | $61.42 | $34.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 15 |
| Target Price | ★ $53.80 | $37.21 |
| AVG Volume (30 Days) | 714.9K | ★ 1.6M |
| Earning Date | 11-04-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $642,780,000.00 | $435,826,000.00 |
| Revenue This Year | $26.71 | $120.36 |
| Revenue Next Year | $20.19 | $37.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 22.40 | ★ 114.22 |
| 52 Week Low | $18.59 | $12.91 |
| 52 Week High | $69.26 | $37.50 |
Technical Indicators
Market Signals| Indicator | XMTR | TVTX |
|---|---|---|
| Relative Strength Index (RSI) | 56.77 | 53.18 |
| Support Level | $58.51 | $33.49 |
| Resistance Level | $64.98 | $36.17 |
| Average True Range (ATR) | 3.32 | 1.57 |
| MACD | 0.00 | -0.26 |
| Stochastic Oscillator | 63.02 | 48.51 |
Price Performance
Historical ComparisonAbout XMTR Xometry Inc.
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.